Prognostic impact of somatostatin receptor expression in advanced bladder cancer
- 7 August 2020
- journal article
- research article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 38 (12) , 935.e17-935.e28
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: Effect of mono- and bi-specific somatostatin analogs on cell growthMolecular and Cellular Endocrinology, 2014
- Somatostatin receptors: From signaling to clinical practiceFrontiers in Neuroendocrinology, 2013
- Somatostatin and somatostatin receptors: implications for neoplastic growth and cancer biologyExpert Opinion on Investigational Drugs, 2009
- Identification of Prognostic Biomarkers for Prostate CancerClinical Cancer Research, 2008
- Treatment with 90Y- and 177Lu-DOTATOC in patients with metastatic neuroendocrine tumorsSurgery, 2006
- Somatostatin and Its Receptor FamilyFrontiers in Neuroendocrinology, 1999
- Molecular pharmacology of somatostatin receptor subtypesJournal of Endocrinological Investigation, 1997
- Somatostatin-14 and its analog octreotide exert a cytostatic effect on GH3 rat pituitary tumor cell proliferation via a transient G0/G1 cell cycle block.Endocrinology, 1995
- Cell Cycle Dependent Induction of Apoptosis by Somatostatin Analog SMS 201-995 in AtT-20 Mouse Pituitary CellsBiochemical and Biophysical Research Communications, 1995
- Somatostatin receptors in human cancer: Incidence, characteristics, functional correlates and clinical implicationsThe Journal of Steroid Biochemistry and Molecular Biology, 1992